FDA approves drug for Alzheimer's patients, first in nearly 20 years

The drug will reportedly treat slow cognitive decline in early-stage patients.

Published: June 7, 2021 11:19am

Updated: June 7, 2021 11:25am

The Food and Drug Administration of Monday approved the first drug to treat Alheimer's patients since 2003, according to multiple news reports. 

The drug will treat slow cognitive decline in early-stage patients, according to The Washington Post.

Unlock unlimited access

  • No Ads Within Stories
  • No Autoplay Videos
  • VIP access to exclusive Just the News newsmaker events hosted by John Solomon and his team.
  • Support the investigative reporting and honest news presentation you've come to enjoy from Just the News.
  • Just the News Spotlight

    Support Just the News